Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Infection Control and Hospital Epidemiology|October 18, 2021
Impact of number of lumens in central-venous catheters on central-line bloodstream infection (CLABSI) and venous thromboembolism (VTE) risk in patients with acute leukemiaAlina Varabyeva, Christabel Pui-See Lo, Adamo Brancaccio, et al.
Leukemia Research|June 17, 2018
The FOSSIL Study: FLAG or standard 7+3 induction therapy in secondary acute myeloid leukemiaVera Vulaj, Anthony J Perissinotti, James R Uebel, et al.
Leukemia & Lymphoma|June 14, 2022
Solving coagulation conundrums: comparing prophylaxis strategies in adult patients receiving PEG-asparaginaseYeeAnn Chen, Kaitlyn Buhlinger, Anthony J Perissinotti, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 7, 2021
Utility of methicillin-resistant Staphylococcus aureus (MRSA) nasal screening in patients with acute myeloid leukemia (AML)Millicynth Talagtag, Twisha S Patel, Gianni B Scappaticci, et al.
Haematologica|March 20, 2025
Recognition, prevention, and management of adverse events associated with asparaginase / pegaspargase treatment of acute lymphoblastic leukemia in adults: consensus of an expert panelEmily Curran, Marlise R Luskin, Houda Alachkar, et al.
Leukemia & Lymphoma|May 18, 2019
A single-center multidisciplinary approach to managing the global Erwinia asparaginase shortageBernard L Marini, Julia Brown, Lydia Benitez, et al.
The Journal of Antimicrobial Chemotherapy|May 6, 2017
Multicentre study of posaconazole delayed-release tablet serum level and association with hepatotoxicity and QTc prolongationNatasha N Pettit, Marisa H Miceli, Christina G Rivera, et al.
Leukemia & Lymphoma|March 29, 2022
Multicenter comparison of first salvage chemotherapy versus novel therapy regimens in adult relapsed/refractory acute lymphoblastic leukemiaMadeleine A Ochs, Bernard L Marini, Lydia L Benitez, et al.
Leukemia & Lymphoma|April 8, 2021
Multicenter comparison of high-dose cytarabine-based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemiaLydia L Benitez, Anthony J Perissinotti, Caitlin R Rausch, et al.
American Journal of Hematology|March 26, 2025
Multicenter Retrospective Evaluation of Treatment for High-Risk Acute Promyelocytic Leukemia: Real-World Outcomes From the HERO ConsortiumLydia L Benitez, Kayleigh R Marx, Caitlin R Rausch, et al.
Pageof 7